Skip to content
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • Home
  • Contact Us
  • About Us
  • Sitemap
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
  • General
  • Business
  • Education
  • Government
  • Medical
  • Entertainment
  • Sports
  • French
  • Press Releases
    • PR-French
Search
Day: October 2, 2024

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More

Duck Creek Technologies Launches Payments Facilitator to Create End-To-End Insurance Payment Solution

October 2, 2024

New Solution Simplifies Insurance Carriers’ Payments Delivering Secure Transaction Capabilities as Part of the Proven Duck Creek Platform BOSTON, Oct. 02, 2024 (GLOBE NEWSWIRE) —

Read More

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More

Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma

October 2, 2024

First program to combine Recursion’s end-to-end suite of AI-enabled active learning modules, resulting in target identification to IND enabling studies in under 18 months Plan

Read More
Page1 Page2 Page3 … Page7
RECENT POSTS

2026 World Cup Leaves Mark with Record Attendance and Controversies

July 20, 2026

2026 World Cup Leaves Mark with Record Attendance and Controversies

July 20, 2026

DRC’s Neighbors Bolster Ebola Preparedness Amid Rising Cases

July 20, 2026

DRC’s Neighbors Strengthen Ebola Preparedness Amidst Rising Cases

July 20, 2026

DRC’s Neighbors Strengthen Ebola Preparedness Amidst Rising Cases

July 20, 2026

2026 World Cup: The Tournament That Changed Football Forever

July 20, 2026

2026 World Cup: The Tournament That Changed Football Forever

July 20, 2026

African Development Bank Group Allocates $13 Million for Ebola Outbreak Response in Central Africa

July 20, 2026
Copyright © 2026 Le Congo Tribune. All Rights Reserved.